{"id":"https://openalex.org/W4294584269","doi":"https://doi.org/10.5603/ep.a2022.0047","title":"Therapy of obesity in women with PCOS using GLP-1 analogues \u2014 benefits and limitations [Terapia oty\u0142o\u015bci u kobiet z PCOS przy zastosowaniu analog\u00f3w GLP-1 \u2014 korzy\u015bci i ograniczenia]","display_name":"Therapy of obesity in women with PCOS using GLP-1 analogues \u2014 benefits and limitations [Terapia oty\u0142o\u015bci u kobiet z PCOS przy zastosowaniu analog\u00f3w GLP-1 \u2014 korzy\u015bci i ograniczenia]","publication_year":2022,"publication_date":"2022-06-30","ids":{"openalex":"https://openalex.org/W4294584269","doi":"https://doi.org/10.5603/ep.a2022.0047","pmid":"https://pubmed.ncbi.nlm.nih.gov/36059178"},"language":"pl","primary_location":{"id":"doi:10.5603/ep.a2022.0047","doi":"https://doi.org/10.5603/ep.a2022.0047","is_oa":true,"landing_page_url":"https://doi.org/10.5603/ep.a2022.0047","pdf_url":"https://journals.viamedica.pl/endokrynologia_polska/article/download/EP.a2022.0047/67671","source":{"id":"https://openalex.org/S81330323","display_name":"Endokrynologia Polska","issn_l":"0423-104X","issn":["0423-104X","2299-8306"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","medline","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320293","host_organization_name":"Via Medica","host_organization_lineage":["https://openalex.org/P4310320293"],"host_organization_lineage_names":["Via Medica"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endokrynologia Polska","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.viamedica.pl/endokrynologia_polska/article/download/EP.a2022.0047/67671","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023539895","display_name":"Agnieszka Baranowska-Bik","orcid":"https://orcid.org/0000-0001-6477-8485","observed_orcids":["https://orcid.org/0000-0001-6477-8485"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Agnieszka Baranowska-Bik","raw_affiliation_strings":["Department of Endocrinology, Centre of Postgraduate Medical Education; Biela\u0144ski Hospital, Warsaw, Poland. abaranowska@cmkp.edu.pl","Biela\u0144ski Hospital, Warsaw, Poland","Department of Endocrinology, Centre of Postgraduate Medical Education"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology, Centre of Postgraduate Medical Education; Biela\u0144ski Hospital, Warsaw, Poland. abaranowska@cmkp.edu.pl","institution_ids":[]},{"raw_affiliation_string":"Biela\u0144ski Hospital, Warsaw, Poland","institution_ids":[]},{"raw_affiliation_string":"Department of Endocrinology, Centre of Postgraduate Medical Education","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5023539895"],"corresponding_institution_ids":[],"apc_list":{"value":500,"currency":"EUR","value_usd":539},"apc_paid":{"value":500,"currency":"EUR","value_usd":539},"fwci":0.3218,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.30175913,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":99},"biblio":{"volume":"73","issue":"3","first_page":"627","last_page":"643"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polycystic-ovary-syndrome","display_name":"polycystic ovary syndrome","score":0.9990000128746033},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.9879999756813049},{"id":"https://openalex.org/keywords/glp-1-analogues","display_name":"GLP-1 analogues","score":0.8939999938011169},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7429999709129333},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9879999756813049},{"id":"https://openalex.org/keywords/hyperandrogenism","display_name":"hyperandrogenism","score":0.9710000157356262},{"id":"https://openalex.org/keywords/hyperinsulinemia","display_name":"hyperinsulinemia","score":0.7940000295639038},{"id":"https://openalex.org/keywords/pregnancy-outcomes","display_name":"pregnancy outcomes","score":0.5630000233650208},{"id":"https://openalex.org/keywords/obesity-pharmacotherapy","display_name":"obesity pharmacotherapy","score":0.6710000038146973}],"concepts":[{"id":"https://openalex.org/C2780186808","wikidata":"https://www.wikidata.org/wiki/Q10529545","display_name":"Hyperandrogenism","level":5,"score":0.8511021733283997},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8134326934814453},{"id":"https://openalex.org/C3018442814","wikidata":"https://www.wikidata.org/wiki/Q500816","display_name":"Polycystic ovary","level":4,"score":0.8009077310562134},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.7508053779602051},{"id":"https://openalex.org/C2780586474","wikidata":"https://www.wikidata.org/wiki/Q332428","display_name":"Overweight","level":3,"score":0.7109727263450623},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.5798279643058777},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.578558623790741},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.5410988926887512},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5294684171676636},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.35143494606018066}],"mesh":[{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011085","descriptor_name":"Polycystic Ovary Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D011085","descriptor_name":"Polycystic Ovary Syndrome","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D011085","descriptor_name":"Polycystic Ovary Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017588","descriptor_name":"Hyperandrogenism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017588","descriptor_name":"Hyperandrogenism","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D050177","descriptor_name":"Overweight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.5603/ep.a2022.0047","doi":"https://doi.org/10.5603/ep.a2022.0047","is_oa":true,"landing_page_url":"https://doi.org/10.5603/ep.a2022.0047","pdf_url":"https://journals.viamedica.pl/endokrynologia_polska/article/download/EP.a2022.0047/67671","source":{"id":"https://openalex.org/S81330323","display_name":"Endokrynologia Polska","issn_l":"0423-104X","issn":["0423-104X","2299-8306"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","medline","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320293","host_organization_name":"Via Medica","host_organization_lineage":["https://openalex.org/P4310320293"],"host_organization_lineage_names":["Via Medica"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endokrynologia Polska","raw_type":"journal-article"},{"id":"pmid:36059178","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36059178","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endokrynologia Polska","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.5603/ep.a2022.0047","doi":"https://doi.org/10.5603/ep.a2022.0047","is_oa":true,"landing_page_url":"https://doi.org/10.5603/ep.a2022.0047","pdf_url":"https://journals.viamedica.pl/endokrynologia_polska/article/download/EP.a2022.0047/67671","source":{"id":"https://openalex.org/S81330323","display_name":"Endokrynologia Polska","issn_l":"0423-104X","issn":["0423-104X","2299-8306"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","medline","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320293","host_organization_name":"Via Medica","host_organization_lineage":["https://openalex.org/P4310320293"],"host_organization_lineage_names":["Via Medica"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endokrynologia Polska","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8500000238418579,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4294584269.pdf","grobid_xml":"https://content.openalex.org/works/W4294584269.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W1418192292","https://openalex.org/W2016986133","https://openalex.org/W2122801878","https://openalex.org/W2151351634","https://openalex.org/W2156291382","https://openalex.org/W2168664376","https://openalex.org/W2346278661","https://openalex.org/W2528009933","https://openalex.org/W2528179062","https://openalex.org/W2651345085","https://openalex.org/W2741878737","https://openalex.org/W2747812115","https://openalex.org/W2770022783","https://openalex.org/W2799507126","https://openalex.org/W2903244266","https://openalex.org/W2922516009","https://openalex.org/W2940562424","https://openalex.org/W2940761224","https://openalex.org/W2941801625","https://openalex.org/W2949103185","https://openalex.org/W2969001662","https://openalex.org/W2983370565","https://openalex.org/W2987017313","https://openalex.org/W3026155818","https://openalex.org/W3037440144","https://openalex.org/W3038172358","https://openalex.org/W3039136404","https://openalex.org/W3083792908","https://openalex.org/W3114360973","https://openalex.org/W3118630608","https://openalex.org/W3120157680","https://openalex.org/W3122503945","https://openalex.org/W3129109569","https://openalex.org/W3132808481","https://openalex.org/W3135963078","https://openalex.org/W3166020479","https://openalex.org/W3192077953","https://openalex.org/W3194466821","https://openalex.org/W3202781181","https://openalex.org/W3203002561","https://openalex.org/W4200098732","https://openalex.org/W4205636865","https://openalex.org/W4206333184","https://openalex.org/W4210987256","https://openalex.org/W4213227897","https://openalex.org/W4213321447","https://openalex.org/W4214727384","https://openalex.org/W4220745740","https://openalex.org/W4221079214","https://openalex.org/W4256605237","https://openalex.org/W4288400169"],"related_works":["https://openalex.org/W4401757839","https://openalex.org/W7113101400","https://openalex.org/W4410223177","https://openalex.org/W4412792397","https://openalex.org/W4402558833","https://openalex.org/W2590409081","https://openalex.org/W4366819379","https://openalex.org/W2566045659","https://openalex.org/W7167038934","https://openalex.org/W4224024335"],"abstract_inverted_index":{"Polycystic":[0],"ovary":[1],"syndrome":[2],"(PCOS)":[3],"is":[4,23,49,59,79,144,185],"a":[5,26,147,160,186,198],"heterogeneous":[6],"endocrine":[7],"disorder":[8],"among":[9],"women":[10,184],"of":[11,28,44,53,66,75,121,124,133,140,149,181,201,229],"reproductive":[12],"age.":[13],"The":[14,138],"incidence":[15],"ranges":[16],"from":[17,92,96],"approx.":[18],"6%":[19],"to":[20,81,214,225],"20%.":[21],"PCOS":[22,183],"characterized":[24],"by":[25],"spectrum":[27],"symptoms":[29],"and":[30,41,70,98,159,173,206,211,216],"clinical":[31,37],"features":[32],"that":[33,167],"includes":[34],"ovarian":[35],"dysfunction,":[36],"and/or":[38],"biochemical":[39],"hyperandrogenism,":[40],"ultrasound":[42],"evidence":[43],"morphologically":[45],"polycystic":[46],"ovaries.":[47],"Obesity":[48],"present":[50],"in":[51,61,72,89,130,156,162,219],"40-70%":[52],"patients":[54,90,135],"with":[55,136,221,231],"the":[56,63,73,111,119,122,131,141,178,226],"syndrome.":[57],"Adiposity":[58],"involved":[60],"exacerbating":[62],"negative":[64],"effects":[65],"insulin":[67,157,217],"resistance,":[68],"hyperinsulinaemia,":[69],"hyperandrogenaemia":[71],"course":[74],"PCOS.":[76,137],"Therefore,":[77,177],"it":[78],"essential":[80],"maintain":[82],"normal":[83],"weight":[84,151,193],"or":[85,104],"effectively":[86],"treat":[87],"overweight/obesity":[88],"suffering":[91],"this":[93,168],"endocrinopathy.":[94],"Apart":[95],"diet":[97],"lifestyle":[99],"interventions,":[100],"an":[101,154],"appropriate":[102],"pharmacological":[103,227],"surgical":[105],"treatment":[106,132,169,180,228],"should":[107],"be":[108],"selected":[109],"for":[110,192,197],"individual":[112],"patient.":[113],"Evidence-based":[114],"data":[115],"have":[116],"unequivocally":[117],"proven":[118],"validity":[120],"use":[123],"glucagon-like":[125],"peptide":[126],"1":[127],"(GLP-1)":[128],"analogues":[129],"overweight/obese":[134],"result":[139],"GLP-1":[142,179,232],"therapy":[143],"not":[145,190],"only":[146,191],"reduction":[148],"body":[150],"but":[152,195],"also":[153,165,196],"improvement":[155],"resistance":[158,218],"decrease":[161],"hyperandrogenaemia.":[163],"It":[164],"seems":[166],"method":[170],"increases":[171],"spontaneous":[172],"in-vitro":[174],"pregnancy":[175],"rates.":[176],"obese":[182],"new":[187],"therapeutic":[188],"opportunity":[189],"loss":[194],"wide":[199],"range":[200],"benefits.":[202],"This":[203],"review":[204],"summarizes":[205],"discusses":[207],"findings":[208],"regarding":[209],"obesity":[210],"its":[212],"relation":[213],"hyperandrogenism":[215],"PCOS,":[220],"special":[222],"attention":[223],"paid":[224],"adiposity":[230],"analogues.":[233]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-09-05T00:00:00"}